Search

Search Constraints

You searched for: Author/Creator Operto, Greg

Search Results

1. Harmonization of amyloid PET scans minimizes the impact of reconstruction parameters on centiloid values: Neuroimaging / Optimal neuroimaging measures for tracking disease progression. (7th December 2020)

2. Multiple pathophysiological biomarkers are associated with gray matter volume and cerebral glucose metabolism in the early preclinical Alzheimer's continuum: Neuroimaging / multi‐modal comparisons. (7th December 2020)

3. Polygenic‐wide analysis to assess the impact of genetic risk profiles on brain morphometry in the ALFA study: Early imaging changes in cognitively normal subjects at risk of late onset AD. (7th December 2020)

4. Impact of APOE‐ε4 on cerebral amyloid deposition in participants with abnormal soluble amyloid levels: Amyloid imaging. (7th December 2020)

5. APOE‐ε4 shapes temporo‐parietal network properties in middle‐aged, cognitively unimpaired individuals: A graph theory analysis: Neuroimaging / imaging and genetics. (7th December 2020)

6. White matter microstructure and cerebrospinal fluid biomarkers of Alzheimer's disease in middle‐aged cognitively unimpaired participants (the ALFA study): Human neuropathology/imaging‐pathologic correlations. (7th December 2020)

7. Impaired default mode network along with increased functional connectivity of the medial temporal lobe as a function of CSF p‐Tau/Ab42 ratio in cognitively unimpaired individuals. (December 2021)

8. Structural, metabolic and cognitive characteristics of cognitively unimpaired subjects with mismatching β‐amyloid biomarkers. (December 2021)

9. Sex differences in genetic susceptibility of hippocampal subfields: A polygenic association study. (December 2021)

10. Imaging neurodegeneration markers are associated with multiple pathophysiological mechanisms in the early stages of the Alzheimer's continuum. (December 2021)